Who is sponsoring NCT03093857?

NCT03093857 is sponsored by RWTH Aachen University.

What drugs are being tested in NCT03093857?

Interventions in NCT03093857: Determination of biomarker.

What condition does NCT03093857 study?

NCT03093857 studies Thoracoabdominal Aortic Aneurysm.

Is NCT03093857 still recruiting?

NCT03093857 is currently status unknown. Last updated 29 March 2017.

Last reviewed 2017-03-29 · How we verify

NCT03093857: TAAA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm

Status unknown Last updated 29 March 2017

What this trial tests

trial testing Determination of biomarker in Thoracoabdominal Aortic Aneurysm in 100 participants. Status unknown.

Timeline

1 June 2014

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	RWTH Aachen University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 June 2014
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Germany

Drugs / interventions tested

Determination of biomarker

Conditions studied

Thoracoabdominal Aortic Aneurysm — all drugs for Thoracoabdominal Aortic Aneurysm →

Sponsor

RWTH Aachen University

Who can join

18 and older, any sex, with Thoracoabdominal Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with a thoracoabdominal aortic aneurysm in need of an endovascular or open operative restructuring will be asked to participate in this study. After obtaining written consent a central venous catheter and a liquor drainage will be routinely placed during surgery. The catheter and the drainage will stay in the patients for at least 72 hours postoperatively. In total, nine measurements of the liquor and serum will be performed within a week in order to determine the following parameters: neuropeptide P, neuropeptide Y, neurofilament triplet protein (NFL), S100B, glial fibrillary protein (GFAp), lactate, glucose, or oxygen.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.
Elhelali A, Hynes N, Devane D, Sultan S, et al · · 2021 · cited 13× · PMID 34085713 · DOI 10.1002/14651858.cd012923.pub2
The Role of Ribonuclease 1 and Ribonuclease Inhibitor 1 in Acute Kidney Injury after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair.
Zechendorf E, Gombert A, Bülow T, Frank N, et al · · 2020 · cited 6× · PMID 33066382 · DOI 10.3390/jcm9103292
Macrophage Migration Inhibitory Factor Predicts Outcome in Complex Aortic Surgery.
Gombert A, Stoppe C, Foldenauer AC, Schuerholz T, et al · · 2017 · cited 3× · PMID 29120365 · DOI 10.3390/ijms18112374

Verify or expand the search:

Other recruiting trials for Thoracoabdominal Aortic Aneurysm

Currently open trials in the same condition.

NCT07147569 — TAMBE Japan Post-Marketing Surveillance · recruiting
NCT06478576 — Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm · NA · recruiting
NCT05758844 — The Safe-line Technique as Additional Attempt to Mitigate Spinal Cord Ischemia After Endovascular Exclusion of TAAA · recruiting
NCT06969729 — Evaluation of Clinical Efficacy and Safety of Aortal Stent-Graft Created Using 3D Printing Technology · NA · recruiting
NCT07141251 — Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02) · Phase 1 · recruiting

Other RWTH Aachen University trials

Trials by the same sponsor.

NCT06390384 — Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric B · NA · not yet recruiting
NCT07322796 — Smoking Cessation Before Bronchoscopy or CT-guided Puncture · recruiting
NCT04996914 — Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma · NA · not yet recruiting
NCT07053956 — Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma · NA · completed
NCT07140536 — The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Perfo · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03093857 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RWTH Aachen University
Last refreshed: 29 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03093857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing